Clinical Trial Update: Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing topical IDP-108 to vehicle evaluated safety and efficacy in patients with onychomycosis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• IDP-108

Snippet

Sponsor: Dow Pharmaceutical Sciences | Conditions: Onychomycosis | Phase 3 | Status: COMPLETED